Physician profile
Thomas J Ellis
NPI 1235234428
$382.76
in general payments reported to CMS, 2019-2025
10 companies · $63.46 in 2025
The $63.46 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.37 · 2021: $85.61 · 2022: $104 · 2023: $55.76 · 2024: $44.93 · 2025: $63.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $172.08 | 2021-2022 | |
| Depuy Synthes Sales INC. | $55.31 | 2023-2025 | Orthovisc, Monovisc |
| Endo Pharmaceuticals INC. | $35.59 | 2022-2023 | Xiaflex |
| Medtronic, INC. | $31.60 | 2024 | Intellis Adaptivestim |
| Ethicon US, LLC | $29.37 | 2020 | |
| Abbott Laboratories | $22.57 | 2023 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $21.22 | 2025 | |
| Bioventus LLC | $15.02 | 2025 | Durolane |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.